Advertisement
Screener

Synergy CHC Corp. (SNYR) EBITDA

Synergy CHC Corp. (SNYR) EBITDA

  • 2026-03-31: Basis Reported; EBITDA (m); Operating income -$567.12K; Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA (m); Operating income $1.28M; Depreciation and amortization (m).
  • 2025-06-30: Basis Reported; EBITDA (m); Operating income $1.62M; Depreciation and amortization (m).
  • 2025-03-31: Basis Reported; EBITDA $1.98M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2023-12-31 to 2025-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-03-31Reported(m)-$567.12K(m)(m)(m)(m)-$2.04M(m)(m)(m)-$13.72K
2025-09-30Reported(m)$1.28M(m)(m)(m)(m)-$2.31M*(m)(m)(m)-$11.11K
2025-06-30Reported(m)$1.62M(m)(m)(m)(m)-$76.95K*(m)(m)(m)$190.11K
2025-03-31Reported$1.98M(m)(m)(m)24.25%(m)-$822.78K(m)(m)(m)-$11.46K
2024-12-31Reported$1.39M(m)(m)(m)13.55%(m)(m)(m)(m)(m)(m)
2024-09-30Reported(m)$1.05M(m)(m)(m)(m)-$237.47K*$2.34M(m)(m)-$192.30K
2024-06-30Reported(m)$1.58M(m)(m)(m)(m)-$281.96K*(m)(m)(m)$179.38K
2024-03-31Reported$1.84M(m)(m)(m)19.57%(m)-$858.04K(m)(m)(m)$127.19K
2023-09-30Reported(m)$2.15M(m)(m)(m)(m)(m)$3.03M(m)(m)-$13.37K
2020-03-31Reported(m)$1.01M(m)$6.12M(m)(m)-$1.30M$1.50M(m)(m)$285.54K
2019-09-30Reported(m)$363.21K(m)$7.36M(m)(m)$753.53K*$2.49M(m)(m)-$57.42K
2019-06-30Reported(m)$705.45K(m)$6.34M(m)(m)$962.64K*$1.61M(m)(m)$40.46K
2019-03-31Reported(m)$1.82M(m)$9.47M(m)(m)$813.71K$2.54M(m)(m)-$5.91K
2018-09-30Reported(m)$639.60K(m)$9.19M(m)$0.00*$1.33M*$2.95M(m)(m)-$126.19K
2018-06-30Reported(m)-$95.94K(m)$9.73M(m)$7.58K*-$232.10K*$2.74M(m)(m)$222.39K
2018-03-31Reported(m)$425.91K(m)$9.70M(m)$121.51K$944.65K$2.81M(m)(m)$160.61K
2017-09-30Reported(m)$444.94K(m)$9.18M(m)$27.85K*-$2.33M*$2.66M(m)(m)$97.71K
2017-06-30Reported(m)-$92.30K(m)$9.32M(m)$22.94K*$1.63M*$2.46M(m)(m)-$167.76K
2017-03-31Reported(m)$3.16M(m)(m)(m)$53.59K$1.68M(m)(m)(m)$291.47K
2016-09-30Reported(m)$2.93M(m)(m)(m)$53.74K*$2.53M*(m)(m)(m)$264.38K
2016-06-30Reported(m)$1.93M(m)(m)(m)$93.95K*$294.83K*(m)(m)(m)$211.18K
2016-03-31Reported(m)$2.64M(m)(m)(m)$62.92K$3.43M(m)(m)(m)$183.91K
2015-09-30Reported(m)$87.16K(m)(m)(m)$2.39K*$595.31K*(m)(m)(m)(m)
2015-06-30Reported(m)$259.76K(m)(m)(m)$0.00*-$290.50K*(m)(m)(m)(m)
2015-03-31Reported(m)-$130.68K(m)(m)(m)$1.65K$495.22K(m)(m)(m)$0.00
2014-09-30Reported(m)-$142.24K(m)(m)(m)(m)-$165.90K*(m)(m)(m)(m)
2014-06-30Reported(m)-$642.49K(m)(m)(m)(m)-$231.98K*(m)(m)(m)(m)
2014-03-31Reported(m)-$2.07K(m)(m)(m)(m)-$570.00(m)(m)(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported(m)-$8.46M(m)(m)(m)(m)-$2.59M(m)(m)(m)$117.47K
2024-12-31Reported$5.93M(m)(m)(m)17.04%(m)-$4.80M$11.19M(m)(m)$102.08K
2023-12-31Reported$10.84M(m)(m)(m)25.34%(m)$421.73K$10.70M(m)(m)$234.98K
2019-12-31Reported(m)-$7.96M(m)$29.36M(m)(m)$2.95M$9.14M(m)(m)-$131.54K
2018-12-31Reported(m)-$4.92M(m)$33.82M(m)$129.09K$1.30M$11.04M(m)(m)$247.69K
2017-12-31Reported(m)$1.82M(m)$35.60M(m)$153.02K-$831.07K$9.82M(m)(m)$316.01K
2016-12-31Reported(m)$2.93M(m)(m)(m)$302.23K$6.04M(m)(m)(m)$944.36K
2015-12-31Reported(m)$486.02K(m)(m)(m)$7.83K-$644.32K(m)(m)(m)$389.94K
2014-12-31Reported(m)-$958.09K(m)(m)(m)(m)-$489.18K(m)(m)(m)$0.00

Similar stocks

Stock NameCountryMarket CapPE Ratio
Functional Brands Inc. (MEHA)United States$0.001B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
MANNATECH INC (MTEX)United States$0.014B
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Canopy Growth Corp (CGC)$0.395B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87